
无数据
无数据
无数据
| CAS Number | 104227-87-4 |
| Catalog Number | AG003QKM(AGN-PC-0OT2CB) |
| Chemical Name | Famciclovir |
| IUPAC Name | [2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate |
| InChI | InChI=1S/C14H19N5O4/c1-9(20)22-6-11(7-23-10(2)21)3-4-19-8-17-12-5-16-14(15)18-13(12)19/h5,8,11H,3-4,6-7H2,1-2H3,(H2,15,16,18) |
| InChI Key | GGXKWVWZWMLJEH-UHFFFAOYSA-N |
| MDL Number | MFCD00866964 |
| Molecular Formula | C14H19N5O4 |
| Molecular Weight | 321.3318 |
| NSC Number | 758921 |
| SMILES | C(CC(COC(=O)C)COC(=O)C)n1c2c(nc1)cnc(n2)N |
| UNII | QIC03ANI02 |
| Synonyms | 9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine,
BRL 42810,
BRL-42810,
BRL42810,
famciclovir,
Famvir,
famciclovir,
104227-87-4,
Famvir,
Famciclovirum,
BRL-42810,
Famciclovirum [INN-Latin],
2-(2-(2-Amino-9H-purin-9-yl)ethyl)propane-1,3-diyl diacetate,
BRL 42810,
Famciclovir (Famvir),
Anti-Farnesyl Rabbit pAb,
UNII-QIC03ANI02,
2-[(acetyloxy)methyl]-4-(2-amino-9H-purin-9-yl)butyl acetate,
FCV,
9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine,
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate,
QIC03ANI02,
1,3-Propanediol, 2-(2-(2-amino-9H-purin-9-yl)ethyl)-, diacetate (ester),
CHEBI:4974,
GGXKWVWZWMLJEH-UHFFFAOYSA-N,
C14H19N5O4,
2-(2-(2-Amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate (ester),
MFCD00866964,
9-(4-acetoxy-3-(acetoxymethyl)but-1-yl)-2-aminopurine,
NCGC00095133-01,
2-(2-(2-amino-9H-purin-9-yl)ethyl)-1,3-propanediol diacetate,
2-[2-(2-amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate,
DSSTox_CID_3038,
DSSTox_RID_76845,
DSSTox_GSID_23038,
[2-(acetoxymethyl)-4-(2-aminopurin-9-yl)butyl] acetate,
Oravir,
Acetic acid 2-acetoxymethyl-4-(2-amino-purin-9-yl)-butyl ester,
2-(acetoxymethyl)-4-(2-amino-4,5-dihydro-9H-purin-9-yl)butyl acetate,
2-[2-(2-Amino-9H-purin-9-yl)ethyl]trimethylene diacetate;2-[2-(2-Amino-9H-purin-9-yl)ethyl]trimethylene diacetate,
SMR000466375,
Famvir (TN),
Famciclovir [USAN:BAN:INN],
CAS-104227-87-4,
SR-01000759358,
Famciclovir (JAN/USAN/INN),
Famciclovir [USAN:INN:BAN],
1,3-propanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, diacetate (ester),
2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol diacetate (ester),
HSDB 8121,
Famciclovir,(S),
Famciclovir(Famvir),
IN1338,
1,3-diyl diacetate,
Spectrum_000466,
AC1L1FOB,
Spectrum2_001101,
Spectrum3_001675,
Spectrum4_000611,
Spectrum5_001548,
CHEMBL880,
SCHEMBL2949,
BSPBio_003489,
KBioGR_001162,
KBioSS_000946,
MLS000759505,
MLS001424115,
MLS006011896,
SPECTRUM1505201,
SPBio_001202,
DTXSID0023038,
CTK8B7737,
Famciclovir, >=98% (HPLC),
KBio2_000946,
KBio2_003514,
KBio2_006082,
KBio3_002709,
KS-00000XOD,
HMS1922L09,
HMS2051G22,
HMS2090G10,
HMS2093K12,
HMS2232H09,
HMS3262O08,
HMS3370D14,
HMS3393G22,
HMS3656A04,
HMS3715F03,
Pharmakon1600-01505201,
ALBB-027262,
BCP21312,
Diacetyl 6-deoxy-9-(4-hydroxy-3-hydroxymethyl-but-1-yl)guanine,
ZINC1530635,
Tox21_111442,
Tox21_500793,
AK-120,
ANW-58321,
CCG-39277,
CF0039,
NSC758921,
s2467,
STK623204,
AKOS005556609,
Tox21_111442_1,
AB07547,
AC-8066,
AN-8356,
CS-1357,
DB00426,
KS-5020,
MCULE-6850246103,
NC00156,
NSC-758921,
NCGC00095133-02,
NCGC00095133-03,
NCGC00095133-04,
NCGC00095133-06,
NCGC00261478-01,
AJ-26674,
AK-82773,
BC201648,
CJ-23991,
CPD000466375,
HY-17426,
I789,
SAM001246732,
SC-43883,
SBI-0206743.P001,
AB0013893,
AB2000579,
LS-120147,
RT-012693,
F0842,
FT-0602549,
SW197536-3,
A19583,
D00317,
K-0411,
2-(2-(2-amino-9H-purin-9-yl)ethyl)propane-,
AB00639952-06,
AB00639952-08,
AB00639952_09,
AB00639952_10,
227F874,
I03-0096,
J-001134,
SR-01000759358-4,
SR-01000759358-5,
9-(4-acetoxy-3-acetoxymethylbut-1-yl)-2-aminopurine,
BRD-K45033733-001-02-3,
BRD-K45033733-001-05-6,
9-[4-acetoxy-3-(acetoxymethyl)butyl]-2-amino-9h purine,
[2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)-butyl] acetate,
Famciclovir, United States Pharmacopeia (USP) Reference Standard,
1,3-Propanediol, 2-[2-(2-amino-9H-purin-9-yl)ethyl]-, 1,3-diacetate,
Famciclovir, Pharmaceutical Secondary Standard; Certified Reference Material,
2-(2-(2-AMINO-9H-PURIN-9-YL)ETHYL)-1,3-PROPANEDIOL DIACETATE ESTER,
famcivir,
famtrex,
FAMCYCLOVIR,
D0VT8P,
CID3324,
BRL42810,
C14-H19-N5-O4,
CS-O-01512,
B1942,
C060590,
D000077595,
Famciclovir, 98%, Antiviral guanosine analog - 1g 1g,
(2-(acetyloxymethyl)-4-(2-aminopurin-9-yl)-butyl) acetate,
2-[2-(2-Amino-9H-purin-9-yl)ethyl]-1,3-propanediol 1,3-diacetate,
|
| Complexity | 404 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 321.144g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 23 |
| Hydrogen Bond Acceptor Count | 8 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 321.337g/mol |
| Monoisotopic Mass | 321.144g/mol |
| Rotatable Bond Count | 9 |
| Topological Polar Surface Area | 122A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 0 |
| Symbol: | |
| Hazard Class | |
| Hazard statements | H302 |
| Packing Group | |
| Precautionary statements | P280-P305+P351+P338 |
| UN Code |
| Chemical Name: | Batch Number: | |
| Chemical Structure: | CAS Registry No: | |
| Product ID: | ||
| Manufacture Date: | ||
| Storage Temperature: | ||
| Formula: | ||
| Molecular Weight: | ||
| Quantity: |
| Test: | Result: |

